Correlation Between Abeona Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Abeona Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abeona Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abeona Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Abeona Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abeona Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abeona Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Abeona Therapeutics and Pieris Pharmaceuticals
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Abeona and Pieris is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Abeona Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abeona Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Abeona Therapeutics i.e., Abeona Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Abeona Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Abeona Therapeutics is expected to generate 1.97 times less return on investment than Pieris Pharmaceuticals. But when comparing it to its historical volatility, Abeona Therapeutics is 2.83 times less risky than Pieris Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,020 in Pieris Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 605.00 from holding Pieris Pharmaceuticals or generate 59.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abeona Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Abeona Therapeutics |
| Pieris Pharmaceuticals |
Abeona Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abeona Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Abeona Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abeona Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Abeona Therapeutics vs. Tff Pharmaceuticals | Abeona Therapeutics vs. Eliem Therapeutics | Abeona Therapeutics vs. Inhibrx | Abeona Therapeutics vs. Enliven Therapeutics |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |